CGS has a very interesting announcement out this morning about a new test for the early detection of Alzheimer's disease.
http://www.asx.com.au/asxpdf/20121016/pdf/429dklx9rm8pz6.pdf
They have found that people with elevated levels of beta amyloid can be used as a marker for very early stages of the disease.
What they have found is that people who do not display any symptoms of Alzheimers but have high beta amyloid in the brain, over time, showed a subtle but progressive decline in their memory.
This sounds like further evidence supporting PBT's research with their candidate PBT2, which works by preventing the accumulation of the beta amyloid protein in the brain.
This story continues to become more compelling over time.
- Forums
- ASX - By Stock
- ATH
- new alzheimer's detection test
new alzheimer's detection test
Featured News
Add ATH (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
-0.001(25.0%) |
Mkt cap ! $15.96M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.3¢ | $2.809K | 936.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 663612 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 156555752 | 64 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 663612 | 0.003 |
77 | 102205685 | 0.002 |
26 | 140640147 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 156555752 | 64 |
0.005 | 8366584 | 12 |
0.006 | 16581534 | 13 |
0.007 | 53884874 | 26 |
0.008 | 35028137 | 27 |
Last trade - 10.18am 13/11/2024 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online